A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Cytokinetics Inc.

About Cytokinetics Inc:

Cytokinetics, Inc. (Nasdaq: CYTK) is a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. A number of commonly used drugs and a growing body of research validate the role that the cytoskeleton plays in a wide array of human diseases. Cytokinetics focus on the cytoskeleton enables them to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease, fungal diseases and other diseases.

Cytokinetics has two drug candidates for the treatment of cancer, a drug candidate for the treatment of acute congestive heart failure and more than ten other research programs. Their most advanced drug candidate is SB-715992. Cytokinetics' second KSP inhibitor is SB-743921.


Product Pipeline Data for Cytokinetics


Oncology Program: SB-715992 for: Monotherapy -- Leukemia, solid tumors, non-small cell lung cancer, breast, ovarian, colorectal, prostate, head and neck, and melanoma.


More on Cytokinetics:


Home Page

Key Statistics for Cytokinetics

Basic Chart for Cytokinetics

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.